A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
复制标题

DOI:
10.1016/j.biopsych.2010.07.015
复制
发表时间:
2010-12-01
影响因子:
10.6
通讯作者:
Geller, Daniel A.
Geller, Daniel A.
中科院分区:
医学1区
文献类型:
--
作者:
Storch, Eric A.;Murphy, Tanya K.;Goodman, Wayne K.;Geffken, Gary R.;Lewin, Adam B.;Henin, Aude;Micco, Jamie A.;Sprich, Susan;Wilhelm, Sabine;Bengtson, Michael;Geller, Daniel A.

文献摘要

参考文献

被引文献

相似文献

Research on the neural circuitry underlying fear extinction has led to the examination of d-cycloserine (DCS), a partial agonist at the NMDA receptor in the amygdala, as a method of enhancing exposure therapy outcome. Preliminary results have supported the use of DCS to augment exposure therapy in adult anxiety disorders; however, no data have been reported in any childhood anxiety disorder. Thus, we sought to preliminarily examine if weight-adjusted DCS doses (25 or 50mg) enhanced the overall efficacy of cognitive-behavioral therapy (CBT) for pediatric obsessive-compulsive disorder (OCD). Participants were 30 youth (ages 8–17) with a primary diagnosis of OCD. The study design was a randomized, double-blinded, placebo-controlled augmentation trial examining CBT+DCS versus CBT+Placebo (15 youth per group). All patients received 7 E/RP sessions paired with DCS or placebo taken 1 hour prior to sessions. Although not significantly different, compared to the CBT+Placebo group, youth in the CBT+DCS arm showed small-to-moderate treatment effects (d=.31 to .47 on primary outcomes). No adverse events were recorded. The present results complement findings in adult OCD and non-OCD anxiety disorders and provide initial support for a more extensive study of DCS augmentation of CBT among youth with OCD.
DOI: 10.1001/archpsyc.63.3.298
发表时间: 2006-03-01
影响因子: --
作者:
Hofmann, SG;Meuret, AE;Otto, MW
通讯作者: Otto, MW
DOI: 10.1016/s0006-3223(99)00127-4
发表时间: 1999-11-01
影响因子: 10.6
作者:
Ressler, KJ;Nemeroff, CB
通讯作者: Nemeroff, CB
DOI: 10.1001/archpsyc.61.11.1136
发表时间: 2004-11-01
影响因子: --
作者:
Ressler, KJ;Rothbaum, BO;Davis, M
通讯作者: Davis, M
DOI: 10.1016/j.biopsych.2006.03.084
发表时间: 2006-08-15
影响因子: 10.6
作者:
Davis, Michael;Ressler, Kerry;Richardson, Rick
通讯作者: Richardson, Rick
DOI: 10.1016/j.biopsych.2009.07.036
发表时间: 2010-02-15
影响因子: 10.6
作者:
Otto, Michael W.;Tolin, David F.;Pollack, Mark H.
通讯作者: Pollack, Mark H.